If you have any question, please feel free to email us. We will touch with you as soon as possible.
CAS:211427-08-6
Source:Korea
Qualifications:/-/JDMF/-/KDMF
| Name | Diquafoxol |
|---|---|
| Chinese name | 地夸磷索四钠 |
| Cas Number | 211427-08-6 |
| Source | Korea |
| Qualifications | /-/JDMF/-/KDMF |
Diquafoxol is a P2Y2 receptor agonist dry eye treatment drug launched in Japan by Santen Pharmaceutical in 2010, and has been approved for marketing in many countries in Europe and Asia. The drug is the first P2Y2 receptor agonist eye drops approved for marketing in the world. It improves the symptoms of dry eye by promoting the secretion of water and mucin, and makes the tear film closer to normal. According to IMS statistics and forecasts, my country’s ophthalmic prescription drug market will maintain a compound growth rate of 20%. The dry eye market has a large capacity. There is no domestic imitation of this product, and it will be a popular imitation product in the next few years.
Hot Tags: diquafoxol api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Ranolazine API, Tetrabenazine API, Letrozole API, Clofarabine API, Bemeprost API, Teriflunomide API
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China
